Tirzepatide (Mounjaro) Based on results from a 72-week trial, estimated weight loss at 68 weeks is approximately 22% for the highest dose (15 mg)
UK health officials are planning to study the link between GLP-1 use and acute pancreatitis, following an increase in reported cases this year
Andrew Dilley, an agricultural economics graduate student, conducted the study under the guidance of Brandon McFadden, Professor and Tyson Endowed Chair in Food Policy Economics
GLP-1 specifically binds to the glucagon-like peptide-1 receptor (GLP-1R) in the body, directly stimulating the secretion of insulin by pancreatic -cells, promoting proliferation and differentiation, and inhibiting cell apoptosis, thereby exerting a glycemic lowering effect
Pernicious Anemia: Parenteral vitamin B 12 is the recommended treatment and will be required for the remainder of the patient's life